# OnCo record radionuclide-therapy-patient-release-criteria (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/radionuclide-therapy-patient-release-criteria/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "radionuclide-therapy-patient-release-criteria" ;
  schema:name "Release of patients after radionuclide therapy or a permanent implant: criteria, instructions and records"@en ;
  schema:alternateName "patient release criteria"@en, "discharge after radionuclide therapy"@en, "release after radioiodine"@en, "release after Lutathera"@en, "release after Pluvicto"@en, "10 CFR 35.75"@en, "dose constraints for carers and comforters"@en, "retained activity limit"@en, "radioactive patient discharge"@en, "release of patients with permanent implants"@en ;
  schema:description "After some treatments with radioactive medicines or seeds, you give off a little radiation for a while. Before you go home, the team checks that the people around you will receive only a small, safe dose, taking your home and family into account, and gives you written instructions. If that is not yet possible you stay in a single room until it is."@en ;
  schema:url <https://onco.cc/protocols/radionuclide-therapy-patient-release-criteria/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:related <https://onco.cc/protocols/radioiodine-therapy-home-radiation-safety/>, <https://onco.cc/protocols/lutetium-177-therapy-home-radiation-safety/>, <https://onco.cc/protocols/permanent-prostate-seed-brachytherapy-home-radiation-safety/> ;
  onco:technologies <https://onco.cc/technologies/radioiodine-therapy/>, <https://onco.cc/technologies/lu177-radioligand-therapy/>, <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/mibg-theranostics/>, <https://onco.cc/technologies/ldr-seed-brachytherapy/> ;
  onco:drugs <https://onco.cc/drugs/radioactive-iodine/>, <https://onco.cc/drugs/pluvicto/>, <https://onco.cc/drugs/lutathera/>, <https://onco.cc/drugs/radium-223/> ;
  onco:institutions <https://onco.cc/institutions/iaea/> ;
  onco:terms <https://onco.cc/terms/radioiodine-term/> .